Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State
CONCLUSION: The provision of 2 units of CCP was associated with a reduction in mortality in patients treated with high titer units within 3 days of COVID-19 diagnosis. Given the results, CCP is a viable, low-cost therapy in resource-constrained states and countries.